Willow Biosciences Inc (WLLW) Price & Analysis

Q: What is Willow Biosciences’s market cap?

Willow Biosciences’s market cap is C$1.45M.

Q: When is Willow Biosciences’s upcoming earnings report date?

Willow Biosciences’s upcoming earnings report date is May 14, 2025 which is in 10 days.

Q: How were Willow Biosciences’s earnings last quarter?

Willow Biosciences released its earnings results on Mar 25, 2025. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.

Q: Is Willow Biosciences overvalued?

According to Wall Street analysts Willow Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Willow Biosciences have?

Willow Biosciences has 144,846,540 shares outstanding.

Q: What happened to Willow Biosciences’s price movement after its last earnings report?

Willow Biosciences reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -33.333%.

Compare

35 Followers

WLLW Stock Chart & Stats

Day’s Range― - ―

52-Week Range<C$0.01 - C$0.15

Previous CloseN/A

Volume134.80K

Average Volume (3M)519.81K

Market Cap

C$1.45M

Enterprise ValueC$11.03M

Total Cash (Recent Filing)C$28.50K

Total Debt (Recent Filing)C$0.00

Price to Earnings (P/E)―

Beta0.69

Next Earnings

May 14, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.05

Shares Outstanding144,846,540

10 Day Avg. Volume1,104,229

30 Day Avg. Volume519,808

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

Price to Cash Flow (P/CF)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

---

Willow Biosciences Inc News

PremiumCompany Announcements

Willow Biosciences Sells Subsidiary, Implements Management Changes

3d ago

PremiumCompany Announcements

Willow Biosciences Reports Key Shareholder Meeting Outcomes

8d ago

PremiumCompany Announcements

Willow Biosciences Reports 2024 Financial Results and Subsidiary Sale

1M ago

PremiumCompany Announcements

Willow Biosciences to Sell Subsidiary Epimeron USA for $3.38 Million

2M ago

PremiumCompany Announcements

Willow Biosciences Initiates Strategic Review Amidst Market Challenges

3M ago

PremiumCompany Announcements

Willow Biosciences Shifts to Less-Dilutive Financing

4M ago

PremiumCompany Announcements

Willow Biosciences Launches $2M Private Placement

6M ago

PremiumCompany Announcements

Willow Biosciences Sees Record Q3 Revenue Growth

6M ago

See All TSE:WLLW News

---

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

4.14% Insiders

―

Mutual Funds

0.30% Other Institutional Investors

95.57% Public Companies and

Individual Investors

Detailed Ownership Overview >

WLLW FAQ

What was Willow Biosciences’s price range in the past 12 months?

Willow Biosciences lowest stock price was <C$0.01 and its highest was C$0.14 in the past 12 months.

What is Willow Biosciences’s market cap?

Willow Biosciences’s market cap is C$1.45M.

When is Willow Biosciences’s upcoming earnings report date?

Willow Biosciences’s upcoming earnings report date is May 14, 2025 which is in 10 days.

How were Willow Biosciences’s earnings last quarter?

Willow Biosciences released its earnings results on Mar 25, 2025. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.

Is Willow Biosciences overvalued?

According to Wall Street analysts Willow Biosciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Willow Biosciences pay dividends?

Willow Biosciences does not currently pay dividends.

What is Willow Biosciences’s EPS estimate?

Willow Biosciences’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Willow Biosciences have?

Willow Biosciences has 144,846,540 shares outstanding.

What happened to Willow Biosciences’s price movement after its last earnings report?

Willow Biosciences reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -33.333%.

Which hedge fund is a major shareholder of Willow Biosciences?

Currently, no hedge funds are holding shares in TSE:WLLW

---

Company Description

Willow Biosciences

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.

---

WLLW Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"NaN":"―"}},"plotLines":[{"color":"rgba(0,0,0,0)","label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[null,null,null,null,null],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2019","6":"Apr<br/>2019","9":"Jul<br/>2019","12":"Sep<br/>2019","25":"Sep<br/>2020"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,{"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.55,0.5076923076923078,0.4653846153846154,0.42307692307692313,0.3807692307692308,0.3384615384615385,0.2961538461538462,0.2538461538461539,0.21153846153846156,0.16923076923076924,0.12692307692307692,0.08461538461538465,0.04230769230769238,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,{"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.55,"date":1538352000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1541030400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1543622400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1546300800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1548979200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1551398400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1554076800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1556668800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1559347200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1561939200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1564617600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1567296000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":0.55,"date":1567296000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >